Oriana Romano

Via U. Bassi, 59/b
Padova, 35131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

FIERCE: reconstructing dynamic trajectories from the differentiation potency of single cells.

FIERCE: reconstructing dynamic trajectories from the differentiation potency of single cells.

Journal: Bioinformatics (Oxford, England)

Published: February 24, 2026

Base editing of β0-thalassemia mutations as a therapeutic strategy for severe β-hemoglobinopathies.

Base editing of β0-thalassemia mutations as a therapeutic strategy for severe β-hemoglobinopathies.

Journal: Science translational medicine

Published: November 26, 2025

Multiplex base editing of BCL11A regulatory elements to treat sickle cell disease.

Multiplex base editing of BCL11A regulatory elements to treat sickle cell disease.

Journal: Cell reports. Medicine

Published: May 15, 2025

RUNX2 cooperates with SREBP1 to rewire cancer metabolism and promote aggressiveness.

RUNX2 cooperates with SREBP1 to rewire cancer metabolism and promote aggressiveness.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 24, 2025

Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies.

Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies.

Journal: Nucleic acids research

Published: January 10, 2025

A 3D morphogenetic blueprint for metastatic outgrowth in breast cancer.

A 3D morphogenetic blueprint for metastatic outgrowth in breast cancer.

Journal: Cell

Published: December 03, 2024

A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis.

A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis.

Journal: Molecular therapy. Methods & clinical development

Published: May 24, 2024

Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses.

Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responses.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 26, 2024

High-throughput transcriptome analyses from ASPIRO, a phase 1/2/3 study of gene replacement therapy for X-linked myotubular myopathy.

High-throughput transcriptome analyses from ASPIRO, a phase 1/2/3 study of gene replacement therapy for X-linked myotubular myopathy.

Journal: American journal of human genetics

Published: March 28, 2023

Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies.

Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies.

Journal: Molecular therapy. Nucleic acids

Published: July 30, 2022

Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression.

Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression.

Journal: Nature communications

Published: January 06, 2022

popsicleR: A R Package for Pre-processing and Quality Control Analysis of Single Cell RNA-seq Data.

popsicleR: A R Package for Pre-processing and Quality Control Analysis of Single Cell RNA-seq Data.

Journal: Journal of molecular biology

Published: November 30, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026